Brown & Brown, Inc. (BRO) Earnings Call Transcript & Summary

July 28, 2026

New York Stock Exchange US Financials Insurance earnings 73 min

What were the key takeaways from Brown & Brown, Inc.'s July 28, 2026 earnings call?

In the second quarter of fiscal year 2026, Brown & Brown, Inc. reported total revenues of $1.7 billion, reflecting a 30.4% increase year-over-year. Adjusted earnings per share grew nearly 4% to $1.07, which was slightly ahead of expectations despite ongoing pressure from declining CAT property rates. Management maintained guidance for organic growth in retail and specialty distribution, projecting retail organic growth (excluding contingents) between 1.5% to 2.5% and specialty distribution organic growth between 2% to 4%. The company continues to focus on strategic acquisitions and share repurchases as part of its capital allocation strategy.

What topics did Brown & Brown, Inc. cover?

  • Organic Growth Focus: Management emphasized their commitment to organic growth, stating, "We're very focused on our organic growth with and without contingents." They noted that organic revenue decreased by 70 basis points from the prior year but increased by 70 basis points when including organic contingents, which they view as a positive outcome.
  • Acquisition Strategy: Brown & Brown acquired six small agencies during the quarter, which contributed to their revenue growth. Management stated, "We're focused on buying back our stock... and looking at acquisitions that are strategic in nature, not solely for scale."
  • AI Partnerships: The company announced partnerships with McKinsey, Accenture, and Anthropic to enhance their AI capabilities, which management believes will enable better customer outcomes and improve operational efficiency. They stated, "We believe new technologies and AI will enable our teammates."
  • Market Conditions and Pricing: Management noted that CAT property rates continue to decline, stating, "In property, CAT rates continue to decrease 15% to 35%." They expect admitted rates to moderate slightly but do not foresee significant changes in the near term.
  • Segment Performance: Retail segment revenues grew by 35.9%, driven by acquisition activity and organic growth, while specialty distribution experienced a decline in organic revenue of 1.6% with contingents. Management highlighted that specialty distribution was impacted by delayed new business revenue, stating, "These organic revenue metrics were negatively impacted by nearly 200 basis points due to approximately $10 million of delayed new business revenue for one of our programs."

What were Brown & Brown, Inc.'s July 28, 2026 results?

  • Revenue: $1.7 billion (+30.4% YoY)
  • Adjusted EPS: $1.07 (+4% YoY)
  • EBITDAC Margin: 35.7% (-100 basis points YoY)
  • Cash Flow from Operations: $610 million (+13% YoY)
  • Retail Organic Growth: 2.5% (including contingents)
  • Specialty Distribution Organic Revenue: -1.6% (with contingents)

Brown & Brown's strong revenue growth and strategic focus on organic growth and technology investments position the company favorably in a competitive market. However, ongoing pressure from declining CAT property rates and pricing competition in the specialty distribution segment pose risks. Investors should monitor the effectiveness of AI initiatives and the integration of acquisitions as potential catalysts for future growth.

Earnings Call Speaker Segments

J. Powell Brown

executive
#1

Thank you, Michelle, and hello everyone, welcome to the earnings call for our second quarter. We're happy with how the quarter went, but before getting into those results, I want to talk about several subjects investors keep raising regarding both our company and the broader industry. To start, we're paying close attention to organic growth both including and excluding contingents. It's worth remembering that when contingents are included, our organic growth offers a better apples-to-apples view against peer brokers, since the majority of them don't disclose their contingent commissions separately. That's the reason we began providing these extra performance metrics in 2026. When it comes to organic, we look at it quarter by quarter and also for the year so far, since the numbers for contingents are going to move around relative to earlier quarters or earlier years. Turning to how we allocate capital: our priority stays on bringing in skilled individuals who can help expand the business organically toward $8 billion and past that. After that, we're putting attention on repurchasing our shares. Right now, we still see buying back stock as a good way to use capital. Last, we're examining acquisitions that make strategic sense rather than ones pursued just to get bigger. And third, you've likely noticed what we announced about teaming up with McKinsey, Accenture and Anthropic. With these partners, we're speeding up what we've already accomplished in AI, and they're also helping us consider the bigger picture of how these tools can be applied holistically. Our view is that emerging tech and AI will empower the people on our teams. What drives us is improving results for customers and giving our teammates the means to reach the market quicker, operate with greater efficiency, and show up better prepared. There's more on AI coming later in this discussion. Let's shift now to the numbers; we're happy with how we performed financially this quarter, landing slightly above what we had projected, despite ongoing headwinds from CAT property rates that keep falling. The results you're seeing come from the hard work put in by our outstanding group of professionals, along with their dedication to providing risk management solutions to the customers we serve. I'll share a few observations about how we performed, conditions in the insurance markets, and our client base. After that, Andy will walk through the financials in greater depth. To finish, I'll offer some closing remarks about the back half of the year and technology, and then we'll take your questions. I'm looking at Slide 4. During Q2, our revenues came in at $1.7 billion, which represents total growth of 30.4%. Organic revenue was down 70 basis points versus the same period last year, though it rose 70 basis points once organic contingents are factored in. Considering that Q2 represents the peak period for CAT property placements annually, we regard this as a solid outcome. Adjusted EBITDAC margin came in at 35.7%, down 100 basis points, while adjusted earnings per share rose almost 4%, reaching $1.07. During the initial half of 2026, we produced healthy operating cash flow and bought back more shares over the quarter. We also completed the acquisition of 6 small agencies. Now turning to Slide 5. Economically speaking, conditions in Q2 stayed fairly in line with what we saw in prior quarters. When it comes to how customers are spending, things have been steady on the whole, and the majority of them still aren't leaning strongly one way or the other when it comes to making an investment. The labor picture looks fairly consistent, and capital investment choices are staying modest throughout most of the economy. Some customers are expanding a great deal depending on which industry they're in, while others are shrinking. We're also picking up some favorable audit premium movement, which points to continued growth at many businesses. From what our customers told us over the quarter, the main things they're keeping an eye on are inflation, oil prices and wider geopolitical matters. Those worries are affecting how people feel, but up to this point we have not seen any significant change in activity levels as a whole. Turning to pricing in commercial insurance, rate changes in Q2 were broadly consistent with Q1, although a handful of lines moderated somewhat more; in the admitted market, rates were generally consistent with Q1 of '26. Workers' comp along with non-cap property were largely flat to negative 5, and when it comes to casualty, the market's behavior differs between primary and excess. Primary casualty and professional liability are largely positive 5%, while excess layers and casualty encountered more pressure on rates. On the property side, CAT rates keep falling 15% to 35%, much like what happened in the first quarter. As we've noted previously, every range has its exceptions, but all in all the CAT property market is still advantageous for our customers. A considerable volume of capital keeps chasing underwriting opportunities, with supply outweighing demand. Some customers are gaining from the softer pricing and keeping those savings, while others are putting the savings toward reshaping their structures, limits or deductibles. Turning to employee benefits, pricing patterns resembled those of the first quarter. Medical costs are still up 8% to 10%, and pharmacy costs climbed above 10% once again; those cost pressures keep driving demand for our advisory and consulting services, since customers want strategies to better control health care and primary costs. All things considered, when we pull back and examine both the economy and the insurance market, customers continue to operate with discipline and are growing modestly. The insurance market stays competitive across many lines, and casualty pressures remain. Given these conditions, we feel our capabilities put us in a strong position to assist customers in navigating the market. I'm now on Slide 6. Let's move on to how our 2 segments performed in the second quarter. In retail, we achieved organic growth of 2.5%, or 1.5% when you strip out contingent commissions. That was a touch better than our forecast, driven by stronger net new business and particularly robust contingent commissions. Our revamped go-to-market sales approach is building momentum, as freshly aligned teams collaborate, uncover opportunities, and secure more new business wins by leveraging our combined strengths. Even though retail's organic growth is improving, it remains below our target. Our people have worked extremely hard to bring 2 large organizations together, and we're making good headway toward stronger organic growth in the coming quarters. My confidence in our team is complete. Now moving to specialty distribution: during this quarter, organic revenue came in at negative 1.6% including contingents, and negative 3.5% excluding them. Roughly $10 million in delayed new business revenue from one of our programs hurt these organic revenue figures by close to 200 basis points. We anticipate recording that revenue largely in Q3. When we factor in this timing along with the softening CAT property rates, the quarter's results matched what we had anticipated. As was the case in the prior quarter, we saw a substantial inflow of submissions, grew our underlying policies in force, and posted yet another excellent quarter for contingents. We see this as evidence of the strength of our capabilities and our underwriting discipline as we expand our base customers; at this point I'd like to hand things over to Andy, who will walk through our financial results in greater detail.

R. Watts

executive
#2

Thanks, Powell, and good morning, everyone. I'll go into more detail on our consolidated results along with some non-GAAP measures. Just a reminder — whenever we talk about EBITDAC, EBITDAC margin, income before income taxes, and diluted net income per share, those figures are on an adjusted basis. We're now on Slide #7. Looking at things on a consolidated basis, total revenues came in at $1.700 billion, which is growth of 30.4% versus the second quarter of 2025. Contingent commissions rose by a notable $40 million, with $24 million of that attributable to Accession. The organic increase underneath was fueled by limited storm claim activity and better underwriting profitability, mainly in our Specialty Distribution segment. On top of that, retail posted a solid quarter for contingents thanks to our improved carrier engagement model. Income before income taxes rose 17.4%, while EBITDAC was up 27%. EBITDAC margin came in at 35.7%, which is a decline of 100 basis points relative to the second quarter of the prior year period. The main driver there was lower interest income compared with the second quarter of last year, when we held cash in preparation for buying Accession. Turning to Accession, we recorded total revenues of roughly $410 million for the quarter, and margins matched our expectations. During the quarter we also sold a noncore retail business that carries nonrecurring annual revenues of about $30 million to $35 million. Our effective tax rate for the quarter was 24.6%, a touch under the second quarter of 2025. Diluted net income per share was up 3.9% to $1.07. Weighted average shares outstanding rose by roughly $41 million to $334 million, largely because of shares issued in connection with the Accession acquisition; that increase was partly offset by about 9 million shares we bought back over the last 9 months. Finally, dividends paid per share were up 10% compared with the second quarter of 2025. Let's move to Slide #8. The Retail segment saw total revenues grow 35.9%; that expansion came mostly from acquisition activity over the past year along with organic growth, including contingent of 2.5%. As for the pharmacy consulting business we discussed previously, the hit to organic growth was roughly 60 basis points this quarter. On the litigation impact tied to individuals who departed and joined the start-up broker, the adjustment to organic revenue for the current period was $18 million. The increase for the first — from the first quarter was mainly due to the effect of earning lower incentive commissions, which we adjusted on a year-to-date basis. Given the information available today, we expect the full year 2026 revenue impact from new and lost business as well as incentives to land in the range of $50 million to $60 million. Our EBITDAC margin was strong, up 230 basis points from the second quarter of last year. That gain came from higher contingents, disciplined expense management and the impact of synergies. For the quarter, we saw a benefit to expenses of roughly 110 basis points from some one-time accrual adjustments. And finally, our margins got a net boost of about 30 to 50 basis points thanks to people who left for the start-up broker; we still expect that benefit to taper off in the quarters ahead as we bring on new teammates. Let's go to Slide #9. In Specialty Distribution, total revenues rose 28.1%, powered by the Accession acquisition and higher contingent commissions — the increase in contingent of $21 million came from $12 million of acquisition activity and $9 million of favorable underwriting performance. Our EBITDAC margin fell 400 basis points to 42.7%, mostly because of weaker unit growth and investments in our European capabilities aimed at supporting additional growth opportunities, which outweighed the higher contingent commissions. A few more remarks on cash flow and the balance sheet; we produced about $610 million of cash flow from operations, up $70 million, or 13%, versus the first half of 2025. For the first 6 months of this year, our ratio of cash flow from operations to total revenues was 17%, against 20% in last year's first half. Two Accession-related items weighed on the current year's cash flow conversion ratio. The first involved nonrecurring related items, with the biggest piece being final earn-out payments that came in above what we had anticipated. The second was working capital timing across the first and second half of the year. Setting those items aside, our underlying cash flow was strong. And finally, over the past 6 months, we put $500 million toward repurchasing approximately 8 billion shares. We still expect robust cash generation for the rest of the year, and we'll balance how we deploy capital among hiring people to help us grow organically, share repurchases, deleveraging and M&A. As for the outlook for the second half of the year, we still believe organic growth will pick up in both divisions, and we anticipate retail organic growth excluding contingents in the range of 1.5% to 2.5%, with organic growth for specialty distribution in the range of 2% to 4%, excluding contingent commissions. With that, let me hand it back to Powell for closing comments.

J. Powell Brown

executive
#3

Thank you, Andy. That was an excellent report. I'm looking at Slide 10. Looking at things through an economic lens, we anticipate that growth across the markets where we do business will stay fairly in line with what we've seen over the past several quarters. Given elevated geopolitical instability and inflation, along with the possibility of interest rates moving higher, we think business leaders are going to stay cautious. Consequently, we anticipate that spending on hiring will stay at levels comparable to those of the past several quarters. Just as they have before, our customers will work their way through today's difficulties while also chasing opportunities to grow. When it comes to pricing, we anticipate that admitted rates will ease a bit, though we don't foresee any major shifts. For E&S rates, we expect the bifurcation to persist: excess casualty will keep rising, while CAT property will fall at a pace comparable to what we saw in the first half of the year. Beyond that, we're noticing that within the E&S space, the admitted market is growing more competitive on certain accounts. Keep in mind that for CAT property placements, the third and fourth quarters are our softest. Turning to integration, we're happy with how far we've come in uniting our teams, which lets us collaborate more deeply and make the most of our capabilities. Just as we told you last quarter, our confidence in our integration work remains strong, and so does our confidence in our capacity to achieve $30 million to $40 million in synergies during this year. On the whole, our team is performing exceptionally well, and I'm happy with the strides we're making. With a solid balance sheet and cash flow, we'll keep concentrating on putting money into our teammates to fuel organic growth, buying back shares, paying down debt, improving our technological abilities and picking up niche firms when the right opportunities arise. What we're aiming for is to put the capital we bring in to work in ways that build shareholder value over the long haul. Finally, we wanted to pick up where we left off last quarter in talking about artificial intelligence and how we see AI potentially affecting our business, our customers and our industry. As we said before, we think AI will serve as an enabler for our company and our teammates. Our focus is on reinventing how we sell and serve, making our underwriting and placement operations as efficient as possible and strengthening our support functions. It's our view that technology won't eliminate the need for risk advisers, brokers or delegated underwriters. Instead, we think it will boost our capabilities, making those people more effective at what they do. Our approach to technology lines up with our ambition of being the top global provider of risk management solutions. To push our journey forward and keep building on the momentum you may have noticed last week, we formed a partnership with Anthropic, MacKenzie and Accenture to assist us in sharpening our strategy and how we carry it out. Every one of these organizations leads in its respective area and contributes particular know-how that will bolster our continuing AI strategy. As we talked about last quarter, we've taken a disciplined approach: first, fostering awareness and education about AI throughout the company, then moving on to pilot initiatives to confirm both the value and the real-world applications. Given how well these programs have performed and the way our teammate has engaged, we're prepared to move forward with the following phase: deliberately compensating important operational areas, such as sales and placement, submissions and underwriting within functional support. We anticipate that this rewiring will produce quicker cycle times, greater productivity and more robust organic growth. At this point, no additional technology spending is being singled out by us. Thanks to what we've invested before and our purchase of Accession, we can shift resources away from running the business and toward data analytics, innovation and AI. Should circumstances shift and an added technology investment need to be flagged, we'll share our plans and what we expect, just as we did previously when we undertook bigger technology investments. On the subject of what to expect, we do foresee added organic growth and margin expansion arriving across the quarters and years ahead as AI, data and analytics grow more deeply integrated into our workflows and those of the industry. To wrap up, we feel terrific about the business, our activity levels and the way the team is drawing on our capabilities. Our attention remains fixed on the customer and on disciplined execution, which puts us in a strong position to deliver improving organic growth and solid bottom line results across the quarters ahead. With that, I'll hand things back to Michelle and open up the lines for Q&A.

Mike Zaremski

analyst
#4

Regarding the Accession integration, I might split this into two parts. Looking at overall revenue for the quarter, excluding the organic difference compared to The Street, it seemed short by no less than a couple of percent. My assumption is that Accession is the reason. Could there be any revenue timing issues or other factors we ought to remember? And for the second part — I'll treat this as my follow-up — about the margin bridge, since Accession is arriving at a substantial rate, can you provide a bridge or some assistance so we can consider how seasonality will affect the figures going forward?

R. Watts

executive
#5

Mike, this is Andy; regarding revenues, in the guidance provided across several quarters, we stated that revenues are fairly evenly distributed among them. For our business, July is a significant month for placements; therefore, that's likely one factor with seasonal patterns that shifts revenues; however, I believe we landed right around 440, 445 in the first quarter and 410 in the second. That aligns quite closely with what we expect for the business, and we didn't provide precise specifics of what we mentioned, a fairly low balance. So nothing out of the ordinary stood out to me there. Then you can get a solid sense toward the year's end from what we reported. Like everyone else, we experienced some disruption from implementing 606. So a few items will likely shift between quarters, but on the whole it ought to be fairly similar for the time being. On the bridge, what we conveyed was that the business operates at roughly a 35% margin overall. So any addition or subtraction to Brown & Brown at the total level will really land near the margins in our specialty distribution, simply due to weighting, since our legacy programs and wholesale business ran above that, but that's pretty much in line with what we expected when we completed the deal.

Mike Zaremski

analyst
#6

All right. And then, real quick, following up on how accession affects cash flow. In your prepared comments, which I found useful, I believe you mentioned an earnout effect. So that won't be reversing; it's, I suppose — should we be thinking about, like, the ongoing earnout effect? Or did this earnout land earlier than we anticipated? I just want to confirm that when we — you still have among the strongest cash flow conversions, and I want to be sure we're modeling that properly going forward.

R. Watts

executive
#7

Sure. Yeah, Mike, what we said there was — that was truly a one-time item tied to earnouts we assumed when the acquisition happened. So we don't expect that same magnitude of hit to cash flow ahead. We continue to believe the business overall will operate at a 24% to 27% cash flow conversion across the long term. We feel very good about that. The organization does see weaker cash flow conversion in the first half compared with the second half, though quite comparable to Brown & Brown.

Mike Zaremski

analyst
#8

Got it. So that's a onetime thing, and despite the tech investments, it's still 24% to 26%.

R. Watts

executive
#9

Yep, that's right.

Greg Peters

analyst
#10

Alright, I want to shift gears and talk about natural revenue expansion, Powell. During the press release, you mentioned having strong momentum going into the latter half of the year. I'm attempting to square that statement with what the figures showed, especially within the specialty segment. There's plenty of talk out there regarding pricing battles, particularly from MGAs. I've got to think that will bleed over and create some weight on your program operations; perhaps you could clarify the momentum you're observing from the inside.

J. Powell Brown

executive
#11

Sure. Let's tackle what you just brought up, since I believe it's quite valid. Within the E&S sector, competition from admitted carriers and programs is heavier now than it used to be, and that's precisely what you'd anticipate when a market is shifting. With that said, keep in mind that we possess all 180 of the new programs, which clearly fall under Arrowhead specialty now, with 81 launching and most of them focused on casualty. I'm not saying that's positive or negative; it simply provides a wider equilibrium across our risk portfolio. The bottom line is we remain extremely rigorous with our underwriting; therefore you're right that it will keep applying pressure to our programs. Yet, as Andy noted, we expect programs to expand roughly between 2% and 4% organically during the back half of the year.

Greg Peters

analyst
#12

All right, I appreciate the response. I suppose my next question is — actually, let me stick with the topic of the pricing cycle. Could you take us through how the accounting works for contingents? Here's my thinking: when there's price competition and rate reductions, especially in property CAT and certain other lines, it feels like there will be a built-in downward pressure, a headwind, affecting the type of contingents available going forward. So could you explain the accounting — are contingents evaluated in real time, or is there some delay involved? The reason I bring this up isn't really about '26; I have '27 and '28 on my mind.

J. Powell Brown

executive
#13

All right. I'll handle one portion of that, and then I'll have Andy handle another portion. Keep in mind that CAT property generally sits within the E&S market, which means it doesn't fall under profit sharing or a contingency. That said, Andy, do you want to speak to Greg's take on how everything else fits in?

R. Watts

executive
#14

Greg, here's perhaps a helpful frame for looking at this — split it into basically two buckets. All right. And when we refer to two buckets. On the retail side of the business, the contingents tend to be fairly steady, but the truth is we can't actually observe the total profitability of the book until the calculations wrap up, and those land next year, which explains why adjustments in both directions keep happening. So we accrue for those policy placements as they move back and forth. Turning to Specialty distribution, we genuinely enjoy strong visibility inside our programs. That means we tweak them according to what we're seeing in terms of profitability for each program. And this may be the point where some folks are potentially having difficulty with this one, since they're imagining that overall profitability across the industry is declining, and therefore a direct correlation to our programs ought to exist. Ours get calculated program by program, and we stay very focused on the profitability we deliver for our areas, and we feel really good about our contingents; that's why, if you look even at the fact that organic, excluding contingents, declined while organic with contingents actually rose. as an organization; so — and we'll keep concentrating on making sure we can deliver solid profitability for our carrier partners.

Elyse Greenspan

analyst
#15

I'd like to return to what was discussed earlier. During the panel, you mentioned some additional hiring you've been doing. So I was hoping to get a bit of an update on the hiring activity you folks have carried out this year — is there an expectation that those newly brought-on producers will help the organic figures you set out for the second half? And then, how should we view hiring as potentially adding to revenue growth next year as well?

J. Powell Brown

executive
#16

Elyse, let me clarify something first — thank you, by the way. Bringing on talented individuals is something we do all the time. That isn't a brand-new or altered approach. I believe drawing that line matters. Still, I want you and everyone else to be clear that organic growth is where our attention sits, and we remain dedicated to bringing in strong people just as we always have. This simply falls under routine business activity; and should we ever choose to make meaningful investments and add fresh talent into the mix, we'd flag that for you, yet nothing of that sort is being flagged at present. Elyse, I just want you and everyone listening to grasp how dedicated we are to expanding our business organically. In my view, that has consistently been — and will remain — what our organization centers on, which means placing the right individuals in the right roles so we can deliver solutions to our customers. Nothing matters more than that. And as I've mentioned before, if you ask what comes next at existing levels, likely it's share repurchases; and beyond that, we have the notion of technology investments along with select M&A.

Elyse Greenspan

analyst
#17

Then for my follow-up, regarding retail—or rather, as you consider that segment—I realize you provided an outlook for the second half, stating a range of roughly 1.5% to 2.5%. Whenever you evaluate those expansion rates, are you merely presupposing the same pricing environment? Also, what I'd really like to know is what you're factoring in for property, correct—basically expecting no active wind season, which appears to be the prevailing assumption right now?

J. Powell Brown

executive
#18

Yeah. Regarding the initial portion of what you asked: indeed, we are working under the assumption that pricing levels are roughly consistent with what we've described. We anticipate some softening in admitted pricing, in our view, for E&S CAT property rates, likely there will be ongoing downward strain absent any occurrence or occurrences, alongside sustained upward strain in specific casualty areas—chiefly those under less strain compared to excess. It's noteworthy, Elyse, that we find ourselves at July's conclusion, and—hardly anyone is bringing up wind season. Thus, looking back historically, over the past 2 years, we experienced subsequent occurrences in September and extending into early October. I'm not predicting anything, yet I find that somewhat noteworthy. However, I have something to ask you, Elyse, if I might—we've consistently separated our organic growth into core, and now we're providing an additional measure including contingents and profit sharing. Meanwhile, the other brokers simply provide a single figure. So what's your take on that? I'm eager to hear if you could offer us some perspective on how you view it?

Elyse Greenspan

analyst
#19

Honestly, from my perspective, I believe every one of us appreciates the extra detail, correct, that your team is sort of presenting at this point alongside, correct, factoring in contingents and excluding them. My sense is that's the case, correct? What I mean is, there's a single additional brokerage, correct, which reports in a comparable manner to what you all do. And everybody else doesn't. Therefore clearly, at this point we're able to examine it from either angle, correct, in order to sort of give your team an even footing.

J. Powell Brown

executive
#20

Answer from J. Powell Brown: Simply wondering. Many thanks, Elyse.

Mark Hughes

analyst
#21

Powell, I might ask you once more to make a prediction about CAT property pricing. Your wording came across as somewhat more positive, and you truly don't anticipate a meaningful shift in the back half compared with the front half? I'm simply kind of wondering if you'd be daring enough to state that a bottom is getting nearer, or who's going to say it?

J. Powell Brown

executive
#22

Yes. Speculating about reaching the bottom isn't something I want to do. What I can share with you, though, is that when you examine rates — and I'll offer one particular region of the country as a point of comparison — if you examine rates in Southeast Florida, a lot of those rates for CAT property along the coast are at 2017 levels right now. They rose extremely fast, and then over a stretch of nearly 2 years they dropped very fast. So the question I pose rhetorically, which I'm unable to answer on your behalf, Mark, is how much further can they decline; and so we have no idea. Broadly speaking — and nobody has raised this so far this time, but I find it somewhat interesting — by this point in the year, someone typically has asked me what it would take for that market to change or stabilize. And painful as it is for me to admit, I believe it's somewhere in the range of $100 billion to $150 billion of losses, which is simply astonishing. That said, we obviously aren't wishing for that. And it wouldn't be good for the Americans affected; but if you send a storm into the Gulf of Mexico while that water is really warm, or up along the Atlantic Coast, along Florida, depending on where it comes in, they could easily produce $100 billion of loss. So I'm not declaring the bottom, and I won't speculate about when we reach the bottom. I'm merely giving you the parameters of what I think it would take to change or stabilize that. And a great deal of competition in property is going to persist in the near to intermediate term.

Mark Hughes

analyst
#23

Got it. This might get a bit into the weeds, but looking at the Florida surplus lines database, you're seeing far more policies in the E&S market, and the premium per policy has dropped quite a bit, yet it appears many more people on the property side, many more policies, are being written in the E&S market. Would that roughly line up with what you're seeing, to whatever degree you track it? And then, what's the reason for that? Why are more people heading into the E&S market?

J. Powell Brown

executive
#24

Alright. So yeah, I would agree with that. And here's a way to think about it from a carrier's perspective: the notion of shifting CAT property, or property in Florida, which in many cases is defined as CAT exposed, hands them flexibility on rate and form rather than a filed rate, and every admitted rate is a filed rate. As you're aware, that means there's a ceiling and a floor. So whether we're talking commercial or residential, what you see is that this gives them greater ability to shift the pricing around, and in the residential space, what the governor and the insurance department are attempting to do is keep a competitive marketplace going. And as you've observed, the depopulation of the residential Citizens program keeps happening. That said, plenty of carriers that historically may have been on large property placements and are admitted want out, since they don't want to hold that exposure themselves, and the E&S market, given the competitive environment, is snapping that business up quickly, though it does hand them flexibility on rate and form.

Tracy Dolin-Benguigui

analyst
#25

Before I ask what I wanted to ask, you requested feedback earlier in the Q&A on those new disclosures, so it would be useful if you restated organic revenue for earlier periods, with contingent included, to make that information more valuable. Now on to my questions. Returning to what we discussed about contingent, very briefly, whenever you work out profitability, given that property isn't the subject here, a tail comes with it. So which policy, or which accident, does your contingent commission stem from? In other words, how many years does that look-back cover?

J. Powell Brown

executive
#26

Okay. Yes. So here's what I'd say — I'll put it very broadly, because the whole question doesn't have a single answer. Some programs focus on just one year; others involve look-backs spanning multiple years. Often, those multiyear look-backs show up in programs and in wholesale. So broadly speaking, what I'd attempt to convey is that retail business tends to be 1 year in nature, while in specialty distribution, it can range from 1 to several years.

R. Watts

executive
#27

Tracy, regarding those multiyear figures, BLC can occasionally include a rolling computation within it. So you could be looking at a 3-year average, meaning there's quite a bit — there are a fair number of subtleties involved in every one of those. As for your initial question about the contingents, we did restate the previous year in the Q. Are you referring to a period even further back? Or do I just need a bit of clarification from you on that point.

Tracy Dolin-Benguigui

analyst
#28

Yeah, additional quarters. Simply to observe their performance across cycles, and so on. That's right. Yeah. All right; and I've got a follow-up regarding the Accession matter; so during the fourth quarter, you provided an updated revenue recognition and essentially stepped back from $430 million to $458 million per quarter, yet your yearly guidance stayed the same, which as I understand it would suggest $1.7 billion to $1.8 billion. So it's encouraging to hear that Accession revenues for the quarter landed where anticipated. However, that would essentially mean the remaining 2 months of the third quarter need to cover the gap. So do you still believe you'll hit your annual guidance?

R. Watts

executive
#29

Yeah. Our view remains that the business will fall within that range. July is a significant month for the business and then also factoring in what we said about divesting a nonring business in retail, roughly 30%, 35%. But no, we feel quite positive about the business and its performance and the growth outlook.

Rob Cox

analyst
#30

When it comes to margin, plenty of factors are in play. Do you currently have any expectation for the full year 2026 margin? I'm just wondering whether you could take us through the larger elements, along with what you've said regarding Accession and the synergies from it, and how that fits with the AI spending — should we anticipate that a smaller portion of the Accession synergies reaches the bottom line?

R. Watts

executive
#31

No, I believe that in our commentary when we entered the year, and in guidance, we indicated we expected margins to be roughly flat, not counting lower investment income, and that was really the income we gained in last year's second quarter, all of it. We still stand by that guidance. Given how we've performed so far this year, we're doing quite well, and the outlook for the latter part of the year remains favorable, in our view. We restate our synergy targets, as Powell told you, at $30 million to $40 million for this year. And regarding the technology spend, this has been a multiyear effort for us, and we discussed it in the first quarter — we have deliberately been shifting our cost away from "that running of the business" and directing a larger share toward data analytics, innovation and AI. So at this point we're quite at ease with where our costs stand, but we are not altering any of our margin guidance for 2026.

Rob Cox

analyst
#32

All right, that's great. And I just want to ask one more thing regarding the chance to serve as clearinghouse administrator for surplus lines in Florida — that position is available to someone. I'm simply wondering whether you might explain the reasons it would or wouldn't be appealing for Brown & Brown to take on that role. And do you have any sense of what it might mean in terms of revenue or profit down the road for whichever broker gets picked?

J. Powell Brown

executive
#33

Well, Rob, to respond to that, clearly our headquarters are in Florida, and expanding what we do in Florida is something we'd like to keep doing, so we think an opportunity does exist for us there. However, right now we aren't going to guess about how that opportunity could shape up while we wait to hear who they actually choose as the winner. And speculating isn't something we'd want to do, since that process has not yet reached its conclusion. After it's resolved, and assuming we turned out to be among the parties under consideration, then maybe we'd discuss it; but as things stand today, speculation is not something we're going to engage in.

Pablo Singzon

analyst
#34

As we begin to consider how Accession fits into Brown's overall organic growth, could you share your view on the way that block has been expanding over the last 2 to 3 quarters? From what you've shared with us so far, it looks as though LTM revenues are coming in at perhaps slightly above 1.7. And at the time you announced your pro forma, revenues stood at roughly 1.7, though possibly somewhat less, correct, since we'd assume you expanded on top of that base. But any kind of perspective you might offer us as you think about presenting Accession over the coming couple of quarters?

R. Watts

executive
#35

Yes. Pablo, moving forward, purely for clarity, we won't be separating out a growth figure for Accession from the growth figure for Brown & Brown. We're one company in there. So that's when we provided guidance in the — toward the end of the year for the second half. So at this stage that is a combined business, since we'll be drawing on our joint capabilities throughout the organization. On comparable business, the business has been growing well. Underlying performance pleases us greatly, and we're extremely pleased with the way all our teammates are leading and helping us grow the organization.

Pablo Singzon

analyst
#36

Got it. Then my next question is about margins. I'd like a clearer picture of how durable that strong 2Q outcome really is. As I recall, you identified roughly 110 bps of a onetime gain in retail; and after that, I believe you pointed to several items — things such as reduced noncash stock comp and fewer claims under Brown's health plan — as what drove floor expenses; so my question, setting aside that onetime accrual, is whether you anticipate these other favorable items carrying into the second half?

R. Watts

executive
#37

No — the onetime items we flagged would not be expected to repeat in the third or fourth quarter.

Pablo Singzon

analyst
#38

Understood. However, items such as reduced noncash stock compensation, decreased claims, and Brown's health plan — I believe those are things referenced in the Q.

R. Watts

executive
#39

Correct, regarding the ones that represent operating expenses, yes, I'd say that with every company, health care expenses always carry uncertainty. And we, similar to nearly every other business, aim to handle our total health care claims carefully. Given how our plan is structured, those typically rise toward the later portion of the year. So we'll monitor how that develops going forward.

Andrew Andersen

analyst
#40

Andrew, just one more thing about Accession, and I realize it accounts for only a modest slice of the total deal value. That said, assuming it's tracking to plan and the integration is going smoothly, could you say a little more about why the 10-Q mentions a decrease in earn-out liabilities caused by weaker projected operating results?

R. Watts

executive
#41

Yeah. Andrew, what we're attempting to accomplish with each of those is that at closing we had to estimate them. And then, once we got the chance to go in and examine the businesses more closely, we refined and adjusted them along the way. I wouldn't characterize that as reflecting the performance underneath. If you look at Brown & Brown, you'll notice that for us it doesn't really happen — typically we don't wind up with meaningful adjustments. Should you go back and review Accession across the last 9 months, the total difference is quite tiny. So we recorded charges late in the year, and this year we adjusted it. But your — I'll refer to it as by. But on a year-to-date basis across the last 9 months, the charge is extremely, extremely minor.

Andrew Andersen

analyst
#42

All right. And on those slides, you noted that potential future M&A might mostly target specialty operations. Is that down to your view that valuations look better in that space, or because you believe specialty represents a bigger strategic opening for the company as you move ahead?

J. Powell Brown

executive
#43

The way I'd frame it, Andrew, is this. Scale alone isn't what occupies our thinking. What occupies our thinking is those with specialized, specialty kinds of capabilities. So don't pin that down — don't interpret that in too literal a fashion. It may be more figurative in nature. That's the way I would put it. But once more, bear in mind, we're bringing — we brought 5,500 new teammates together. A plan is being executed by us, and growing our business organically is something we're very committed to. And as I mentioned previously, our focus is on carrying on with what we've done previously when it comes to hiring good people who can help us grow our business; and right now, share repurchases, debt pay down, investments in technology and selective M&A.

R. Watts

executive
#44

Andrew, I've got something to ask you, and it builds on what you just raised. When you posed that question, did you take away that our focus is exclusively on finding a company operating in the government specialty distribution space? That isn't what we mean at all. Our point is that we're seeking companies possessing areas of expertise, and those could sit within retail or within specialty distribution, yet whatever it is would in the end strengthen what we're able to do as a whole.

J. Powell Brown

executive
#45

Alternatively, we could strengthen what we can do in logistics.

R. Watts

executive
#46

Is that any clearer?

Andrew Andersen

analyst
#47

Right, I'd interpreted that as E&S, so thanks for clearing that up.

Alex Scott

analyst
#48

Regarding specialty distribution, I was hoping you could say more about what you're investing in over in Europe. What sorts of things are underway there? How should that feed into growth as time goes on?

J. Powell Brown

executive
#49

As you probably know, we run a big retail operation in Europe, plus a wholesale business that's growing and is a decent size, and a programs business too. The investments we're talking about sit in wholesale and programs, and those represent chances to grow, and we're bringing on new staff to add fresh specializations and capabilities so that business can expand organically down the road; so we expect opportunities to keep showing up there, just as they will elsewhere across our system, but plenty of talented folks have — quite a few have come aboard, and I believe even more will come aboard as that marketplace keeps shifting and our business keeps expanding there. So the opportunities in front of us in London, in wholesale as well as programs, have us quite pleased.

Alex Scott

analyst
#50

Understood. Let's revisit retail for a moment. I believe someone said that net new business came in somewhat stronger than anticipated during this quarter, and that the momentum keeps growing. Could you walk through a few of the initiatives driving that momentum, and explain why you have confidence to highlight it along with how you're steering guidance for the back half?

J. Powell Brown

executive
#51

Sure. As I mentioned, Alex, and as you're aware, we've rolled out a fresh approach — Steve Hearn and his group have rolled out a fresh go-to-market approach. And we believe we're making better use of what we can do throughout the platform, which benefits our customers. So when we consider where our inventory stands and the new business prospects ahead, that simply mirrors how we're feeling. I'd say EM and I are both encouraged by the strides we're taking in retail and by what lies ahead. I've mentioned this before, and I'll repeat it: expansion at any company doesn't follow a straight path. It isn't a perfectly straight line. So at times you get peaks and valleys. Still, given what we know and observe, we're confident it will land within the ranges we provided. And clearly, we're striving to do even better than that.

Brian Meredith

analyst
#52

For my first question, I'm just interested—do you have any perspective on the NFIP program's reauthorization coming up in September, and where things stand with that?

J. Powell Brown

executive
#53

Yeah, Brian, here's the thing: I've lost track of how many occasions it's been delayed, though 27 is the figure that sticks in my head. What we're seeing are temporary measures—pushing the problem out by 9 months, 10 months, 12 months, 7 months, 5-month extensions. Regrettably, nothing I can see would alter that and lead to a long-term reauthorization; I wish I could tell you more, but that's all we've got.

Brian Meredith

analyst
#54

Thanks for that. Now for my follow-up, I'm simply wondering about the revenues affected by litigation — clearly they came up once more during this quarter. At what point do you expect that to begin standing out in terms of its yearly effect? And leaving aside those producers who departed, what has producer retention looked like otherwise?

J. Powell Brown

executive
#55

All right. Regarding the figure Andy provided to you, that represents a projected impact for the entire year as of right now. Based on everything we're currently observing, we therefore think that's the figure it will land within. So I believe it's worth pointing out. That's the first thing. Second, when it comes to keeping our teammates on board, we're quite happy with how well we've retained them. But I'd like you to understand that whenever you merge 2 organizations, and when you have a situation like that in which an organization has broken the law — that's the starting point — it actually produces a highly uncommon effect of rallying the whole team. With that said, there are 2 ways you can frame it. First, you might call it a terribly negative occurrence, which it was and continues to be, and we're extremely displeased. The other way to frame it is as a team that came together and united quite quickly, with our teammates out in the market alongside our customers and our prospects, side by side. So when I try to determine whether there's something good and something bad, we look for the good, if that makes sense. That's roughly how we see it.

Yaron Kinar

analyst
#56

I just want to return to the start-up, and to those people who have departed, and perhaps connect that with what you said before, Andy, regarding recruiting and the way you would always highlight exceptional hiring efforts. So wouldn't the requirement, or the chance, to fill some of those roles ultimately create an exceptional recruiting opening?

J. Powell Brown

executive
#57

I'll take that one. The brief response is that in the markets that got hit — again, we've treated this as an opening, a tough one, but an opening to bring in more highly capable individuals who are a cultural fit at Brown & Brown. So, as Andy mentioned in his prepared remarks, we haven't yet brought back everyone who left, though we have brought back quite a few. And our aim is to keep seeking out very capable people to join our team in those positions as we keep serving those clients, and as we add new clients to the team.

Yaron Kinar

analyst
#58

Understood. Let me just confirm I've got this right. You could still bring in new people to fill the roles of the ones who departed. It isn't automatically the case that your plan is to hand that work to the team members already in place, or perhaps tilt further toward opportunities driven by institutional technology?

J. Powell Brown

executive
#59

No is the answer. Our intention is to fill the bulk, if not the entirety, of those roles, though certain of those individuals might bring different skills. to assist us in expanding our business going forward; so you can look at it as a good thing. Having a gap in the near term is a bad thing, but it's a good thing that you might be adding individuals who possess different skills that can assist us in expanding our business further down the road.

Yaron Kinar

analyst
#60

Understood. Then the second thing I wanted to ask about is simply examining the contingent commissions within our Specialty Distribution segment. Could you perhaps give us some insight into just how concentrated those contingents happen to be among the top programs in that business?

R. Watts

executive
#61

Yaron, the bulk of those contingents that sit in there are tied to our CAT programs, or they're essentially non-casualty by nature.

Jian Huang

analyst
#62

Let me start with the wider issue of keeping talent and competing for it. You touched on this briefly, I realize. Talent competition still seems really fierce. Then you said a quick word about staffing. Could you help us break down what things look like right now for retention and for bringing in new people? And from that angle, how should we view the way this tougher competitive environment affects your company?

J. Powell Brown

executive
#63

All right. Rob, what I'd say is that your point is accurate — the battle for talent is extremely fierce; during other stretches of time it has also been extremely fierce. So I'm not claiming this is something new; fierce it is, and my sense is that in past years the focus tended to sit more on big metro regions. These days, following COVID, it seems to be spread much more widely, almost everywhere. Something that falls to us, or to any other company really, is the ability to spell out the strengths we bring that perhaps competitors lack — and, if we're discussing production teammates specifically, that a teammate brings. When someone joins Brown & Brown, here is the set of services, strengths, or tools in the kit, pick whatever wording you like, that comes with being on our team. Should you be with a different team, those aren't available to you, or perhaps you receive them differently, or something along those lines. So one thing we'll be doing going forward — our core business remains the middle and upper middle market. That hasn't shifted. Yet for a lot of you listening, I'm not sure you completely grasp all the strengths we possess in particular niche segments. Those sit in retail, though they may also sit in specialty distribution; and likewise at both ends of the size range. That means bigger accounts, smaller accounts, specialty accounts, and so forth. So going forward, we'll discuss this a bit more during our earnings calls, just not today. Still, the brief response is that it matters that we view our company as a sports team; and we're aiming to bring the best — not literally, but — athletes onto that team. And so we've built a culture we think is genuinely appealing to the right sort of individual. We think our reward systems push toward the outcomes we want; and our goal is to add more individuals of that kind to the team, which lets us serve the customers we already have and expand alongside new prospects.

Jian Huang

analyst
#64

Understood. That answer is much appreciated. Moving to my next question, which concerns technology and IT expenditures. You discussed the partnership involving Anthropic and MacKenzie, among others. Additionally, your margin is without question the strongest in the sector. Should AI expenses rise in the future — you noted that margin remains a real priority for you. Still, I'm just wondering how we ought to view those possible added AI costs while Brown & Brown scales up its technological capabilities. How should that margin be considered further out, not right away, but perhaps 2027, 2028? Can we frame it in some way?

J. Powell Brown

executive
#65

Okay. To begin, I appreciate it. Of everyone asking questions, you're number 12, and regarding technology, you're the first — so thanks, Rob. Now, the initial point: isn't it fascinating that everyone discusses AI's upside, yet Brown & Brown isn't seeing an EBITDA gain? That's not our focus. Our focus is better outcomes for customers and empowering teammates. We've said we think it will produce added organic growth and improved margins eventually. That part is accurate. My view is nobody right now completely grasps token expenses, usage levels, or the way new technologies get used at work, since I've heard tales of people — not at Brown & Brown, but at other companies — where max users were reviewed, and they approach the individual saying, "Wow, you've accomplished all these wonderful things. What exactly are you doing? Is it truly that deep?" The reply is that they're composing a book. To me, that isn't a business activity. Conversely, some rising users are extremely heavy and put in place things that make the business more efficient, with processes that get streamlined, which then does reduce costs. So in my view, opportunities of every kind exist, and nobody completely grasps them. As I see it, AI's advantages and those of new technology will genuinely appear in years 3, 4, and 5. That isn't to say we won't get certain advantages sooner, but I want everyone to grasp that this is our perspective. Consequently, Andy and I are deeply dedicated not just to deploying new technologies but to confirming the value we expect from them. We're also thrilled to have Dori Henderson serving as our Chief Technology Officer, assisting with that implementation. And when you consider it, the keys to success. And with this technology shift, it's on leaders to take charge, and companies have to play a role in the fix — helping shape what the business becomes, plus the workflows that get better, and after that the entire organization owns the results and the uptake. So a ton of folks say, "hey, this is fantastic; we're going to make it happen." Yet what happens is: plenty of people leave out awareness and training for teammates. Those things matter enormously, and every one of them will shape tech spending going forward. Andy and I, as we've stated for the short term, have attempted to make clear that we don't anticipate added spend, since we're shifting it from one place to another. However, if we actually do, we'll present that to you across specific time frames; and should that hit the margin, then how does it eventually pay off for us later on.

R. Watts

executive
#66

Bob, the reason we pointed out in that section how our value management office is growing is to ensure that, when we move through various use cases, value is being generated from them. And should they prefer not to fail quickly, that’s fine as we sort things out; so our goal is to guarantee we have extremely clear value drivers and KPIs for the different cases.

Matthew Heimermann

analyst
#67

One more thing on that same topic. I suppose my question is: what might make the costs tied to MacKenzie, Accenture, and Anthropic come in above the reallocation you just described? Could it be new systems? Could it be infrastructure? Could it be specific apps? Could it simply be integration costs needed to deliver a use case? I'm just curious what the surprise would be there. Or where might those costs turn out to be unexpected, to the point of needing more investment?

R. Watts

executive
#68

Most likely it hinges on how quickly change can really be rolled out across the company. We made an effort to be very deliberate as we headed into this, shaping our plans around which value streams we'd rewire, and also around how much change the organization can handle. People might want to hear how simple it is, but we have to train our people and get things in place. So at this moment, we're at ease with the projections we have, and with the spending we can take back into our margins. Should anything shift, we'll return, as we told you, and lay that out again for you.

J. Powell Brown

executive
#69

One thing I will say, though, is that we're quite happy with the partners we've got, and we're enthusiastic about what lies ahead. All right. Matt, was there another question?

Matthew Heimermann

analyst
#70

Nah, considering how things lined up, that's everything from me. Thanks for that.

J. Powell Brown

executive
#71

Much appreciated. We'll squeeze in a single additional question and then wrap things up. Question 14.

Roland Mayer

analyst
#72

I really don't want to wrap up by asking about buybacks, but you mentioned a debt maturity coming due that you plan to pay off, based on what you said about repurchases. Have you considered refinancing it instead, so you could repurchase additional shares?

R. Watts

executive
#73

Roland, we'll look at that as the fourth quarter unfolds. There's $400 million maturing in December. Our cash flow is quite strong, which gives us a lot of flexibility. For one thing, we must pay it off since it does come due, and whether we settle the full amount or just part of it is something we'll assess during the fourth quarter.

J. Powell Brown

executive
#74

Thanks, Michelle, and we’re grateful for everyone’s time and effort today. We — and to wrap up, we’re encouraged about what lies ahead when it comes to organic growth in our technology and AI, plus share repurchases made without cost; and fourth, reducing debt and making targeted acquisitions. So we can’t wait to speak with all of you in the next quarter. I hope your day goes well. Thanks a lot.

Operator

operator
#75

That brings us to the end of this conference call. Thanks for joining us, and you're welcome to disconnect at this point. Have a wonderful day, everyone.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Brown & Brown, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Brown & Brown, Inc. earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Brown & Brown, Inc. or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.